Magnus Medical

Magnus Medical is an American medical device company developing a novel, non-invasive brain stimulation technology to treat major depressive disorder (MDD). Magnus Medical’s flagship product, the SAINT Neuromodulation System, has received FDA Breakthrough Device Designation and clearance for the treatment of MDD.

Investment rationale

Magnus has developed a proprietary, personalized, FDA-cleared therapy for treatment-resistant depression with substantially greater response and remission rates than currently available options. It is a large addressable market and the company has strong underlying unit economics.

Headquarters: San Francisco, USA

Website: https://www.magnusmed.com/

Fund: MIM I & MIM II